Blog .

Cellular immunotherapy to cope with Covid-19

Life Sciences

At Inveniam Group, we would like to congratulate Dr. Rafael Correa Rocha, head of the Immune-Regulation Laboratory of Gregorio Marañón Hospital, for participating in a European consortium that promotes research on cellular immunotherapies to cope with Covid-19. The consortium is coordinated by the Hospital Clínic de Barcelona – IDIBAPS with support of the company Cellnex Telecom.

The project, which has an investment of 6 million euros, aims to measure the cellular response of the immune system to the virus and to develop cellular therapies with T-lymphocytes.

Read the whole article here.